Title:
A CREAM-T0-POWDER DERMATOLOGICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO2002072018
Kind Code:
A3
Abstract:
A cream, comprising about 5 to 60 % of a non-swelling clay, a swelling clay, a natural or synthetic gum, a surfactant, a hydrophilic and/or hydrophobic solvent, wherein, after application to a surface, dries to a uniform, visible, substantive, abrasion-resistant powder. The cream/powder composition is useful for a protective skin covering for preventing conditions such as bed sores, diaper rash, poison ivy or soothing uncomfortable feet, or as a delivery vehicle for a therapeutically - active dermatological agent, such as acne or fungal treatments, or as the delivery vehicle for treating other types of conditions, such a sore muscles, sore joints or microbial infections. Methods of making and using the cream also are included.
Inventors:
RIOS LUIS A (US)
FIGUEROA RAMON F (US)
FIGUEROA RAMON F (US)
Application Number:
PCT/US2002/007326
Publication Date:
February 27, 2003
Filing Date:
March 11, 2002
Export Citation:
Assignee:
R F TECHNOLOGY CONSULTANTS INC (US)
RIOS LUIS A (US)
FIGUEROA RAMON F (US)
RIOS LUIS A (US)
FIGUEROA RAMON F (US)
International Classes:
A61K8/02; A61K8/19; A61K8/26; A61K8/39; A61K8/73; A61K8/86; A61K31/74; A61K47/02; A61K47/32; A61K47/36; A61P17/00; A61Q17/00; A61Q19/00; A61Q19/02; A61Q19/08; A61K9/70; (IPC1-7): A01N25/34; A61K7/00; A61K31/74
Foreign References:
| US5578219A | 1996-11-26 | |||
| US5407879A | 1995-04-18 |
Download PDF:
Previous Patent: METHOD OF DRUG TARGET VALIDATION
Next Patent: INTERFERON-BETA POLYNUCLEOTIDE THERAPY FOR AUTOIMMUNE AND INFLAMMATORY DISEASES
Next Patent: INTERFERON-BETA POLYNUCLEOTIDE THERAPY FOR AUTOIMMUNE AND INFLAMMATORY DISEASES